The Asia Pacific High Intensity Focused Ultrasound Market would witness market growth of 7.7% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific High Intensity Focused Ultrasound Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $137.5 million by 2031. The Japan market is registering a CAGR of 7.2% during 2024-2031. Additionally, the India market would showcase a CAGR of 8.5% during 2024-2031.
The adoption of HIFU technology has been driven by its advantages over traditional invasive procedures. Growing awareness campaigns and educational initiatives have informed patients about the benefits of HIFU. As patients become more informed about non-invasive treatment options, demand for HIFU has increased.
HIFU systems are increasingly integrated into a wider range of medical facilities, from specialized treatment centres to general hospitals. This increased availability improves access to HIFU for a broader patient population. The appeal of HIFU’s minimal recovery time compared to traditional surgical options has driven patient demand. Patients favour HIFU for its convenience and reduced impact on their daily lives.
The high prevalence of cancer in India, combined with economic constraints, drives the demand for affordable and effective treatment technologies. HIFU’s potential for cost-efficiency compared to traditional cancer treatments can make it a sought-after option in India’s healthcare sector. In 2021, the projected cancer burden in India is expected to increase from 26.7 million DALYs (adjusted mortality to incidence) to 29.8 million in 2025. The north and northeast regions are anticipated to experience the highest burden.
The rising cancer burden may lead to increased support from the Indian government and non-governmental organizations (NGOs) for incorporating HIFU into cancer treatment programs. This support could include funding for HIFU technology and initiatives to integrate it into public health systems. To meet the demand for cancer treatment technologies in India, there could be a push to develop and manufacture HIFU devices locally. This can reduce costs and make HIFU more accessible to the Indian population. Thus, the region's high treatment costs and increasing cancer burden drive the market's growth.
The China market dominated the Asia Pacific High Intensity Focused Ultrasound Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $137.5 million by 2031. The Japan market is registering a CAGR of 7.2% during 2024-2031. Additionally, the India market would showcase a CAGR of 8.5% during 2024-2031.
The adoption of HIFU technology has been driven by its advantages over traditional invasive procedures. Growing awareness campaigns and educational initiatives have informed patients about the benefits of HIFU. As patients become more informed about non-invasive treatment options, demand for HIFU has increased.
HIFU systems are increasingly integrated into a wider range of medical facilities, from specialized treatment centres to general hospitals. This increased availability improves access to HIFU for a broader patient population. The appeal of HIFU’s minimal recovery time compared to traditional surgical options has driven patient demand. Patients favour HIFU for its convenience and reduced impact on their daily lives.
The high prevalence of cancer in India, combined with economic constraints, drives the demand for affordable and effective treatment technologies. HIFU’s potential for cost-efficiency compared to traditional cancer treatments can make it a sought-after option in India’s healthcare sector. In 2021, the projected cancer burden in India is expected to increase from 26.7 million DALYs (adjusted mortality to incidence) to 29.8 million in 2025. The north and northeast regions are anticipated to experience the highest burden.
The rising cancer burden may lead to increased support from the Indian government and non-governmental organizations (NGOs) for incorporating HIFU into cancer treatment programs. This support could include funding for HIFU technology and initiatives to integrate it into public health systems. To meet the demand for cancer treatment technologies in India, there could be a push to develop and manufacture HIFU devices locally. This can reduce costs and make HIFU more accessible to the Indian population. Thus, the region's high treatment costs and increasing cancer burden drive the market's growth.
List of Key Companies Profiled
- EDAP TMS S.A
- Sonablate Corp.
- Verasonics, Inc.
- ALPINION MEDICAL SYSTEMS Co., Ltd.
- Theraclion
- Lynton Lasers Ltd
- ULTRAISER
- PROFOUND MEDICAL CORP.
Market Report Segmentation
By End Use
- Hospital
- Imaging Centers
- Others
By Application
- Dermatology
- Uterine Fibroids
- Prostate Cancer
- Essential Tremor
- Breast Cancer
- Glaucoma
- Backpain, Facetogenic
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific High Intensity Focused Ultrasound Market by End Use
Chapter 5. Asia Pacific High Intensity Focused Ultrasound Market by Application
Chapter 6. Asia Pacific High Intensity Focused Ultrasound Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- EDAP TMS S.A
- Sonablate Corp.
- Verasonics, Inc.
- ALPINION MEDICAL SYSTEMS Co., Ltd.
- Theraclion
- Lynton Lasers Ltd
- ULTRAISER
- PROFOUND MEDICAL CORP.
Methodology
LOADING...
